Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02282943
Other study ID # EC71/02
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2002
Est. completion date June 2016

Study information

Verified date March 2019
Source Royal Surrey County Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare laser CO2 ablation/excision of Endometriosis (AFS stages 1-3) with excision of endometriosis using the Ethicon Harmonic ACE device. Pain scores at 6 months was the primary outcome, but secondary outcomes assessed pain scores at 1, 3 and 5 years as well as psychological state and quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 112
Est. completion date June 2016
Est. primary completion date December 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Endometriosis grade I-III by revised American Fertility Society Scoring

- Patients in whom laser treatment to the endometriosis is considered the treatment of choice.

- Patients having consented to participated in the trial

- Patient is 18 years old or greater

- Patients who have no contraindications to either of the treatment modalities proposed

Exclusion Criteria:

- Patients who do not wish to participate/have not signed the informed consent form

- Pregnancy of breast feeding

- Patients who are unable or unwilling to discontinue hormonal treatment for 6 months

- Patients who have received additional treatment for their endometriosis within 6 months of surgery

- Patients with documented painful conditions of the gastrointestinal or urinary system

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Laser
Vapourisation/excision of endometriosis AFS stages I-III using CO2 laser
Harmonic scalpel
Excision of endometriosis using Harmonic scalpel

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mr Andrew Kent

Outcome

Type Measure Description Time frame Safety issue
Primary Visual analogue pain score (VAS) change at 6 months compared to preoperative baseline 6 months
Secondary Quality of life survey (Endometriosis Health Profile Questionnaire) 0, 3, 6 months and 1,3,5 years
Secondary Psychological state Hospital Anxiety & Depression Scale 0, 3 ,6 months and 1,3,5 years
Secondary Visual analogue pain score (VAS) change from baseline 1,3 and 5 years
See also
  Status Clinical Trial Phase
Completed NCT01931670 - A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Phase 3
Recruiting NCT05648669 - A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain Phase 3
Completed NCT04081532 - The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain N/A
Recruiting NCT06101303 - Endometriosis Pain
Completed NCT04665414 - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Completed NCT03690765 - Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
Recruiting NCT05153512 - ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
Active, not recruiting NCT04171297 - Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Completed NCT04565470 - Strategies of Self-management of Endometriosis Symptoms
Completed NCT03613298 - Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement. N/A
Withdrawn NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Not yet recruiting NCT03464799 - Does Immunotherapy Have a Role in the Management of Endometriosis?
Active, not recruiting NCT03002870 - Characteristics of Patient Population With Endometriosis N/A
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Completed NCT02973854 - Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
Recruiting NCT02481739 - Laparoscopic Surgical Management of Endometriosis on Fertility N/A
Active, not recruiting NCT02754648 - Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve N/A
Completed NCT06106932 - GnRH-a on Angiogenesis of Endometriosis N/A
Completed NCT02387931 - Supplementation in Adolescent Girls With Endometriosis Phase 4